Skip to content

InsiderTradesSIGMA

RecommendationsTOP BasketNEW TerminalNEW

Companies Executives Screeners Performance Blog

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Free account open.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 23 markets

Recommendations
Terminal
Companies
Insiders
Performance
Backtest
Data quality

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive
Insider buying this week
Cluster signals

Methodology
How it works
Glossary
API docs
Blog
RSS
Screeners
Newsletter
Key facts
Data
Insider Confidence Index

About
Contact
Pricing
Sign in
Privacy
Terms
Cookies

Built in Paris. Public sources across 43 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa, among others. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-27. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Free account open · Pro on waitlist·Hosted on Vercel

Built bySimon Azoulay

All systems operational

US-Listed Companies · SEC (Form 4) · InsiderTrades Sigma · page 18

US11,615 companies

US-Listed Companies

Regulator: SEC (Form 4).

Technologie · 5.9M

Amicus Therapeutics, INC.

Santé & Pharma · 4.5B

Amkor Technology, INC.

Technologie · 11.9B

Amneal Pharmaceuticals, Inc.

Santé & Pharma · 6.1B

Ampco Pittsburgh CORP

Industrie · 177.3M

AmperCap Acquisition Co

Amphastar Pharmaceuticals, Inc.

Santé & Pharma · 857.1M

Amphastar Pharmaceuticals, Inc.

Santé & Pharma · 958.4M

Industrie · 197.7B

Ampio Pharmaceuticals, Inc.

Previous 1...10...16 171819 20 30 40 50 60...233 Next

Santé & Pharma · 207.9k

AmpliTech Group, Inc.

Amplify Energy Corp.

Énergie · 197.3M

Amplitude Healthcare Acquisition Corp

Santé & Pharma · 23.6M

Amplitude, Inc.

Technologie · 1.9B

Amprius Technologies, Inc.

Technologie · 1.4B

Amtech Systems INC

Industrie · 256M

Amtrust Financial Services, Inc.

Amylyx Pharmaceuticals, Inc.

Santé & Pharma · 3.9B

Anacor Pharmaceuticals, Inc.

Analog Devices INC

Technologie · 175.3B

Analog Devices, Inc.

Anaptysbio, INC

Santé & Pharma · 1.7B

Anavex Life Sciences CORP.

Santé & Pharma · 309.5M

Andalusian Credit Company, LLC

Andersen Group Inc.

Andersons, Inc.

Agroalimentaire · 2.2B

Andover National Corp

Finance & Banque

Andrea Electronics CORP

Technologie · 6.8k

Anebulo Pharmaceuticals, Inc.

Santé & Pharma · 12.2M

Angel Oak Dynamic Financial Strategies Income Term Trust

Finance & Banque

Angel Oak Financial Strategies Income Term Trust

Finance & Banque · 425.7M

Angel Oak Mortgage REIT, Inc.

Immobilier · 207.8M

Angel Oak Mortgage REIT, Inc.

Immobilier · 207.8M

Angel Oak Mortgage, Inc.

Immobilier · 224.2M

Angel Studios, Inc.

Services aux entreprises · 204.4M

Angiodynamics INC

Santé & Pharma · 655.1M

Angion Biomedica Corp.

Santé & Pharma

AngloGold Ashanti PLC

Anika Therapeutics, Inc.

Santé & Pharma · 282.4M

Anika Therapeutics, Inc.

Santé & Pharma · 283.3M

Anixa Biosciences Inc

Santé & Pharma · 118.4M

Annaly Capital Management INC

Finance & Banque · 17.4B

Annaly Capital Management, Inc.

Santé & Pharma · 936.5M

Annovis Bio, Inc.

Santé & Pharma · 73.3M

Antares Pharma, INC.

Santé & Pharma